Patent ID: 8227513
Filing Date: 2012-07-24
Classification: A23L,A23V,A61P

Abstract:
1. A method for reducing the risk of a cancer of the mouth, the pharynx, the esophagus, the stomach, tile small intestine and the large intestine, comprising administering a non-alcoholic food compositions containing acetaldehyde to humans or for animal feeding, wherein acetaldehyde-binding compound(s) have been added to the food compositions, wherein the acetaldehyde-binding compound(s) is selected from the group consisting of L-cysteine, D-cysteine, cysteic acid, cysteine glycine, threo- or erythro-β-phenyl-DL-cysteine, β-tetramethylene-DL-cysteine, methionine, L-ascorbic acid, D-penicillamine and its dipeptides with N-terminals, semicarbazide, reduced glutathione, β-mercaptoethylamine, D,L-homocysteine, N-acetylcysteine, L-cysteinyl-L-valine, β-β-tetramethylene-DL-cysteine, cysteinyl-glycine, mercaptoethylglycine, tre-(5)-β-phenyl-DL-cysteine, erythro-β-phenyl-DL-cysteine, cysteine hydrochloride, thiamine hydrochloride, or a salt of any of these compounds, and wherein the amount of acetaldehyde-binding compound in the food compositions is from 0.2 mM to 10 mM/1 μM acetaldehyde.